We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

35 hedge funds and large institutions have $147M invested in Loxo Oncology, Inc in 2014 Q3 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
+$44.8M
2
O
OrbiMed
New York
+$28.2M
3
DM
Deerfield Management
New York
+$20.6M
4
BI
BVF Inc
California
+$15.5M
5
RIM
RS Investment Management
California
+$7.78M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Aisling Capital
New York
$45.3M +$44.8M +3,452,493 New
O
2
OrbiMed
New York
$28.6M +$28.2M +2,175,857 New
DM
3
Deerfield Management
New York
$20.9M +$20.6M +1,591,546 New
BI
4
BVF Inc
California
$15.7M +$15.5M +1,192,202 New
RIM
5
RS Investment Management
California
$7.87M +$7.78M +599,400 New
RG
6
Redmile Group
California
$7.09M +$7.01M +540,300 New
DCM
7
Driehaus Capital Management
Illinois
$4.8M +$4.74M +365,566 New
VAM
8
Visium Asset Management
New York
$4.37M +$4.31M +332,516 New
Axa
9
Axa
France
$1.64M +$1.62M +125,000 New
Jennison Associates
10
Jennison Associates
New York
$1.64M +$1.62M +125,000 New
BBA
11
Baker Bros. Advisors
New York
$1.31M +$1.3M +100,000 New
Millennium Management
12
Millennium Management
New York
$1.31M +$1.3M +100,000 New
BFA
13
BlackRock Fund Advisors
California
$1.05M +$1.04M +80,319 New
AWMDMG
14
Austin W. Marxe & David M. Greenhouse
New York
$985K +$973K +75,000 New
NIP
15
Nicholas Investment Partners
California
$963K +$952K +73,341 New
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$662K +$655K +50,449 New
Goldman Sachs
17
Goldman Sachs
New York
$526K +$520K +40,040 New
BIT
18
BlackRock Institutional Trust
California
$365K +$360K +27,765 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$252K +$249K +19,173 New
State Street
20
State Street
Massachusetts
$226K +$222K +17,100 New
SIM
21
Spark Investment Management
New York
$199K +$200K +15,400 New
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$165K +$163K +12,532 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$149K +$147K +11,310 New
Deutsche Bank
24
Deutsche Bank
Germany
$118K +$117K +9,010 New
BIM
25
BlackRock Investment Management
Delaware
$111K +$110K +8,440 New
1
2

LOXO Hedge Fund Activity: Q3 2014 in Review

35 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2014, worth a combined $147M.

Buyers outnumbered sellers: 35 funds opened new LOXO positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Aisling Capital, opening a new position worth an estimated $44.8M.

  • 35 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $147M of Loxo Oncology, Inc stock for Q3 2014.
  • 35 funds opened new Loxo Oncology, Inc positions in Q3 2014 and 0 closed out, a net change of +35 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2014 was Aisling Capital, an estimated $44.8M added.

Based on aggregated 13F filings for Q3 2014.